Ying Shi 1, Wenshuang Wang1, Pengfei Liu1, jianxiu lian2,3,4
1The First Affiliated Hospital of Harbin Medical University, Harbin, China
2Philips Healthcare, Guangzhou, China
3Clinical and Technical Support, Philips Healthcare (Beijing), Beijing, China
4Philips Healthcare (Beijing), Beijing, China
Presenting Author: Ying Shi
Synopsis
Motivation:
Goals:
Approach:
Results:
Full abstract & presentation
The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.
Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.
To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.
1. Brian M A, Timothy F C (2017) Adult Glioblastoma, J Clin Oncol 35 (21). 10.1200/jco.2017.73.0119. [doi]
2. Jigisha P T, Therese A D, Craig H, et al. (2014) Epidemiologic and molecular prognostic review of glioblastoma, Cancer Epidemiol Biomarkers Prev 23 (10). 10.1158/1055-9965.Epi-14-0275. [doi]
3. Elena O, Paz M-M, María O-C, et al. (2024) Glioblastoma Therapy: Past, Present and Future, Int J Mol Sci 25 (5). 10.3390/ijms25052529. [doi]
4. Yue Y, Zhao X. (2021) Melanin-Like Nanomedicine in Photothermal Therapy Applications. Int J Mol Sci 22(1):399.
5. Lesley J, Scott.(2018). Gadobutrol: A Review in Contrast-Enhanced MRI and MRA. Clin Drug Investig, 38(8), 773-784. doi:10.1007/s40261-018-0674-9 [doi]
6. Jia, W H, Tian H L, Jiang J W, et al.(2022). Brain-Targeted HFn-Cu-REGO Nanoplatform for Site-Specific Delivery and Manipulation of Autophagy and Cuproptosis in Glioblastoma. Small, 19(2), e2205354. doi:10.1002/smll.202205354 [doi]
7. Tsvetkov P, Coy S, Petrova B, et al.(2022). Copper induces cell death by targeting lipoylated TCA cycle proteins. Science, 375(6586), 1254-1261. doi:10.1126/science.abf0529 [doi]
8. Huang C H., Chang E, Zheng L, et al.(2023). Tumor protease-activated theranostic nanoparticles for MRI-guided glioblastoma therapy. Theranostics, 13(6), 1745-1758. doi:10.7150/thno.79342 [doi]